2016
DOI: 10.18043/ncm.77.6.416
|View full text |Cite
|
Sign up to set email alerts
|

Challenges in the Screening and Management of Osteoporosis

Abstract: Osteoporosis imposes a significant burden of morbidity, mortality, and cost on patients and the health care system. Compliance with existing screening and treatment recommendations is low. There are multiple barriers to treatment including complexity of medical management, cost of medications, real and perceived side effects of medications, and nonadherence.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Postmenopausal osteoporosis is a progressive deteriorative condition characterized by low bone mass and microarchitectural deterioration of the skeleton, leading to enhanced bone fragility and a consequent increased risk of fracture. 1 It has been estimated that more than one-third of postmenopausal women suffer from primary osteoporosis. 2,3 Postmenopausal osteoporosis may cause not only fractures but also chronic pain.…”
Section: Introductionmentioning
confidence: 99%
“…Postmenopausal osteoporosis is a progressive deteriorative condition characterized by low bone mass and microarchitectural deterioration of the skeleton, leading to enhanced bone fragility and a consequent increased risk of fracture. 1 It has been estimated that more than one-third of postmenopausal women suffer from primary osteoporosis. 2,3 Postmenopausal osteoporosis may cause not only fractures but also chronic pain.…”
Section: Introductionmentioning
confidence: 99%
“…Another health concern that is often associated with age is osteoporosis. Lisa A. LaVallee and colleagues [27] discuss this silent disease in their article in this issue. The authors share information related to the cost, prevalence, and burden of this disease, as well as recommendations for screening, treatment, and care management.…”
mentioning
confidence: 99%